EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bromopride stimulates 5-HT4-serotonin receptors in the human atrium

Lina Maria Rayo Abella, Joachim Neumann, Britt Hofmann, Ulrich Gergs

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04013-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Lina Maria Rayo Abella und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06112, Halle (Saale), …. Hauptthemen laut MEDLINE: Heart Atria, Metoclopramide, Receptors, Serotonin, 5-HT4, Serotonin 5-HT4 Receptor Agonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Martin-Luther-Universität Halle-Wittenberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bromopride, an analogue of metoclopramide, is approved in some countries to treat gastrointestinal diseases. These therapeutic effects of bromopride are explained by antagonism at D 2 -dopamine receptors in the gut and the brain. We tested here the hypothesis that bromopride acts as an agonist or antagonist at the human cardiac 5-HT 4 -serotonin receptors. To this end, the force of contraction (FOC) was measured in isolated human atrial preparations (HAP), in isolated left atrial preparations (LA), and in isolated spontaneously beating right atrial (RA) preparations from mice with cardiac specific overexpression of the human 5-HT 4 -serotonin receptors (5-HT 4 -TG). Bromopride concentration dependently increased FOC in LA from 5-HT 4 -TG. The positive inotropic effect (PIE) of bromopride in LA from 5-HT 4 -TG was abolished by GR125487, a 5-HT 4 -serotonin receptor antagonist. Only in the presence of the phosphodiesterase III inhibitor cilostamide did bromopride raise FOC under isometric conditions in HAP. The PIE of 10 µM bromopride in HAP was extinguished by 1 µM GR125487. When serotonin had elevated FOC in HAP, additionally applied bromopride reduced FOC. These data suggest that bromopride is a partial agonist at human cardiac 5-HT 4 -serotonin receptors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart AtriaMetoclopramideReceptors, Serotonin, 5-HT4Serotonin 5-HT4 Receptor AgonistsMyocardial ContractionHumansAnimalsMiceIn Vitro TechniquesSerotonin 5-HT4 Receptor AntagonistsMaleFemaleMiddle Aged

Stichwörter der Autor:innen

BromoprideHuman atriumMouse atrium

Substanzen

bromoprideMetoclopramideReceptors, Serotonin, 5-HT4Serotonin 5-HT4 Receptor AntagonistsSerotonin 5-HT4 Receptor Agonists

Autor:innen und Institutionen

  • Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06112, Halle (Saale), Germany.
  • Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06112, Halle (Saale), Germany. joachim.neumann@medizin.uni-halle.de.
  • Department of Cardiac Surgery, mid-German Heart Centre, University Hospital Halle, Halle (Saale), Germany.

Förderung

  • Martin-Luther-Universität Halle-Wittenberg

Zitieren

APA

Abella, L. M. R., Neumann, J., Hofmann, B., & Gergs, U. (2025). Bromopride stimulates 5-HT4-serotonin receptors in the human atrium. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04013-1

Vancouver

Abella LMR, Neumann J, Hofmann B, Gergs U. Bromopride stimulates 5-HT4-serotonin receptors in the human atrium. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04013-1

BibTeX
@article{Abella2025,
  author = {Abella, Lina Maria Rayo and Neumann, Joachim and Hofmann, Britt and Gergs, Ulrich},
  title = {Bromopride stimulates 5-HT4-serotonin receptors in the human atrium},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04013-1}
}
Kostenlos starten →